BeOne Medicines AG
ONC
$316.99
-$5.38-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 143.79% | 202.88% | 178.34% | 100.51% | 54.63% |
| Total Depreciation and Amortization | -29.81% | -49.01% | 25.73% | 31.19% | -41.55% |
| Total Amortization of Deferred Charges | 1,287.74% | 29.60% | 388.45% | -0.85% | -68.36% |
| Total Other Non-Cash Items | -30.27% | 30.06% | 13.25% | 21.19% | -11.85% |
| Change in Net Operating Assets | 967.10% | -23.34% | 104.72% | 49.78% | 94.91% |
| Cash from Operations | 455.28% | 113.70% | 375.76% | 114.29% | 118.99% |
| Capital Expenditure | 59.43% | 64.02% | 60.14% | 63.98% | 26.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.73% | -424.23% | -2,005.27% | -23.06% | 99.47% |
| Cash from Investing | 59.05% | 63.20% | 40.01% | 41.89% | 72.32% |
| Total Debt Issued | 58.63% | -- | -22.40% | -47.05% | 8.68% |
| Total Debt Repaid | -40.64% | -19.71% | 31.25% | -4,849.32% | -260.26% |
| Issuance of Common Stock | 118.79% | 396.42% | 495.69% | 328.36% | 665.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 2,243.07% | 7,491.79% | 52.17% | -120.81% | -101.19% |
| Foreign Exchange rate Adjustments | 144.79% | -65.06% | 497.78% | 115.51% | -262.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 768.32% | 1,286.91% | 234.82% | 71.43% | 79.65% |